Nusano
  • Company
    • Leadership
    • Medical Iso Advisory Board
    • Strategic Advisory Board
    • Mission & Values
    • West Valley City
    • Contact Us
  • Technology
  • Batteries
  • Energy
    • HALEU
    • Nuclear Fuel Cycle
  • Industrial
  • Life Sciences
    • Medical Isotopes
    • Request Quote
    • R&D Collaboration
    • About Nuclear Med
  • News
    • Press Releases
    • Video
    • Podcast
    • Email Sign Up
  • Careers
    • Current Openings
    • Life in Utah
Select Page
Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility

Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility

by Scott Larrivee | Aug 21, 2025 | News, Utah

Utah Governor Spencer Cox opens 190,000-square-foot building Nusano platform capable of producing more than 40 different radioisotopes for healthcare and industry New supplies of radioisotopes urgently needed for new and emerging cancer diagnostics and therapeutics...
Nusano Establishes Strategic Advisory Board to Support Innovation Across Company’s Product Verticals

Nusano Establishes Strategic Advisory Board to Support Innovation Across Company’s Product Verticals

by Scott Larrivee | Aug 7, 2025 | News

The Honorable Dr. David J. Shulkin, Corey Johnston and Seema Singh Bhan Appointed as Initial Advisory Board Members WEST VALLEY CITY, Utah – Aug. 7, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the formation of a...
Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes

Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes

by Scott Larrivee | Jul 9, 2025 | News

Pairing of custom-built klystrons and fast-pulse modulators enable production of up 12 radioisotopes in a single run Power and efficiency of Nusano system to surpass existing commercial methodologies Beam time reservations and isotope supply agreements underway WEST...
Talk Radioisotopes: Paul Schrimpf, Proprietor & Entrepreneur, Cyrall

Talk Radioisotopes: Paul Schrimpf, Proprietor & Entrepreneur, Cyrall

by Scott Larrivee | Jun 26, 2025 | Podcast

In this episode of Talk Radioisotopes, host Scott Larrivee and guest Paul Schrimpf, Proprietor and Entrepreneur at Cyrall, unpacks what it takes to build and scale a radiopharmaceutical business. With a background spanning Accenture, Prophet, and leadership roles...
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement

Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement

by Scott Larrivee | Jun 26, 2025 | News

The following is a copy of a press release issued by Cellectar Biosciences Partnership Provides Long-Term Supply of Iodine-125 and Actinium-225 Supports Advancement of Radiotherapeutic Pipeline and Plans to Initiate Phase 1b Clinical Trial of CLR-125 for...
« Older Entries

Recent Posts

  • Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility
  • Nusano Establishes Strategic Advisory Board to Support Innovation Across Company’s Product Verticals
  • Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes
  • Talk Radioisotopes: Paul Schrimpf, Proprietor & Entrepreneur, Cyrall
  • Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement

Recent Comments

No comments to show.
Nusano
Supplying the fight against cancer & enabling life-changing innovations
  • Follow
  • Follow
  • Follow
Company
about us
Leadership
Contact us
technology

The Nusano Platform
R&D Collaboration

Resources
News
Careers
Suppliers
© 2025 Nusano | Web design
Privacy Policy – Terms of Service